Mostra i principali dati dell'item
HBSAG LEVELS DECLINE > 10% DURING 48 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITS B (CHB) FAVORS END OF TREATMENT RESPONSE: PRELIMINARY ANALYSIS OF THE PERSEAS COHORT
dc.creator | Goulis, L. | en |
dc.creator | Akriviadis, E. | en |
dc.creator | Karatapanis, S. | en |
dc.creator | Deutsch, M. | en |
dc.creator | Dalekos, G. N. | en |
dc.creator | Raptopoulou-Gigi, M. P. | en |
dc.creator | Drakoulis, C. | en |
dc.creator | Mimidis, K. | en |
dc.creator | Germanidis, G. | en |
dc.creator | Nikolopoulou, V. | en |
dc.creator | Chounta, A. | en |
dc.creator | Bakalos, G. | en |
dc.creator | Papatheodoridis, G. V. | en |
dc.date.accessioned | 2015-11-23T10:28:51Z | |
dc.date.available | 2015-11-23T10:28:51Z | |
dc.date.issued | 2011 | |
dc.identifier.issn | 0270-9139 | |
dc.identifier.uri | http://hdl.handle.net/11615/28109 | |
dc.source.uri | <Go to ISI>://WOS:000295578003614 | |
dc.subject | Gastroenterology & Hepatology | en |
dc.title | HBSAG LEVELS DECLINE > 10% DURING 48 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITS B (CHB) FAVORS END OF TREATMENT RESPONSE: PRELIMINARY ANALYSIS OF THE PERSEAS COHORT | en |
dc.type | journalArticle | en |
Files in questo item
Files | Dimensione | Formato | Mostra |
---|---|---|---|
Nessun files in questo item. |